Keywords: Grunenthal, Exec VP Latin America, Novartis, Daniel Vasella, Compensation package
Grunenthal aims to strengthen Latin America business, appointing exec VP for the region; Novartis cancels Vasella deal
Article | 19 February 2013
German family-owned drugmaker Grunenthal Group announced the appointment of Oscar Ferenczi, former region head of Sandoz Latin America (a generic ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
